Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)

Clinical trial NCT01453998 · COMPLETED

Trial details

NCT number: NCT01453998
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acellular Pertussis Hepatitis B Haemophilus Influenzae Type b Tetanus Diphtheria Poliomyelitis

Start date: 2011-10-14
Primary completion: 2012-11-12
Enrollment: 657

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.